HomeCompareMAURF vs MRK

MAURF vs MRK: Dividend Comparison 2026

MAURF yields 5.09% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MAURF wins by $1966.60M in total portfolio value
10 years
MAURF
MAURF
● Live price
5.09%
Share price
$15.53
Annual div
$0.79
5Y div CAGR
93.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1966.65M
Annual income
$1,869,995,193.71
Full MAURF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — MAURF vs MRK

📍 MAURF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMAURFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MAURF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MAURF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MAURF
Annual income on $10K today (after 15% tax)
$432.84/yr
After 10yr DRIP, annual income (after tax)
$1,589,495,914.65/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MAURF beats the other by $1,589,487,586.24/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MAURF + MRK for your $10,000?

MAURF: 50%MRK: 50%
100% MRK50/50100% MAURF
Portfolio after 10yr
$983.35M
Annual income
$935,002,495.92/yr
Blended yield
95.08%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

MAURF
No analyst data
Altman Z
1.3
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MAURF buys
0
MRK buys
0
No recent congressional trades found for MAURF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMAURFMRK
Forward yield5.09%2.76%
Annual dividend / share$0.79$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR93.8%32.7%
Portfolio after 10y$1966.65M$56.8K
Annual income after 10y$1,869,995,193.71$9,798.13
Total dividends collected$1959.72M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: MAURF vs MRK ($10,000, DRIP)

YearMAURF PortfolioMAURF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,687$986.87$11,206$366.19+$481.00MAURF
2$14,594$2,088.95$12,650$502.35+$1.9KMAURF
3$20,340$4,724.67$14,407$694.19+$5.9KMAURF
4$33,691$11,926.80$16,585$967.82+$17.1KMAURF
5$71,830$35,780.85$19,342$1,363.89+$52.5KMAURF
6$215,029$138,170.57$22,913$1,947.19+$192.1KMAURF
7$979,243$749,162.81$27,662$2,823.89+$951.6KMAURF
8$7,227,109$6,179,318.73$34,159$4,173.35+$7.19MMAURF
9$90,333,861$82,600,854.32$43,337$6,308.80+$90.29MMAURF
10$1,966,652,425$1,869,995,193.71$56,776$9,798.13+$1966.60MMAURF

MAURF vs MRK: Complete Analysis 2026

MAURFStock

Marui Group Co., Ltd., an investment holding company, engages in the retailing and FinTech businesses in Japan. The company engages in the rental and the management of commercial property, purchasing and sale of clothes and accessories, space production, advertising, fashion distribution, general building management, etc.; and provision of credit card services, cash advance services, rent guarantee services, information system services, real estate rental, etc. It is involved in the operation of Marui/Modi stores, online shopping and mail-order, specialty store, credit loan, collection and management of receivables, design and interior decoration, planning and making of advertisement, trucking, forwarding, software development, building management, and security service businesses. Marui Group Co., Ltd. was founded in 1931 and is headquartered in Tokyo, Japan.

Full MAURF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this MAURF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MAURF vs SCHDMAURF vs JEPIMAURF vs OMAURF vs KOMAURF vs MAINMAURF vs JNJMAURF vs ABBVMAURF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.